Endostatin inhibits the growth and migration of 4T1 mouse breast cancer cells by skewing macrophage polarity toward the M1 phenotype

A lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors

(2015) Emilia Mira et al.   Oncotarget

Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment

(2013) Xin Li et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene

(2013) J Yang et al.   ONCOGENE

Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma

(2012) Huijie Jia et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Decoy Receptor 3 Enhances Tumor Progression via Induction of Tumor-Associated Macrophages

(2012) S.-K. Tai et al.   JOURNAL OF IMMUNOLOGY

Polarization of tumor-associated macrophage is associated with tumor vascular normalization by endostatin

(2012) Qian Peng et al.   Thoracic Cancer

Effects of a human plasma membrane-associated sialidase siRNA on prostate cancer invasion

(2011) Xiaojie Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PlGF

(2011) Charlotte Rolny et al.   CANCER CELL

Transcription factors in myeloid-derived suppressor cell recruitment and function

(2011) Nada Sonda et al.   CURRENT OPINION IN IMMUNOLOGY

Synergistic Suppression of Prostatic Cancer Cells by Coexpression of Both Murine Double Minute 2 Small Interfering RNA and Wild-Type p53 Gene In Vitro and In Vivo

(2011) K. Ji et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice

(2010) Flávia Gomes de Góes Rocha et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Nuclear Factor- B and Tumor-Associated Macrophages

(2010) A. Mancino et al.   CLINICAL CANCER RESEARCH

NF-κB as a central regulator of macrophage function in tumors

(2010) Subhra K. Biswas et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Lack of Collagen XVIII/Endostatin Exacerbates Immune-Mediated Glomerulonephritis

(2010) Y. Hamano et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Regulation of macrophage function in tumors: the multifaceted role of NF- B

(2009) T. Hagemann et al.   BLOOD

Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation

(2009) Alberto Mantovani et al.   HUMAN IMMUNOLOGY

“Re-educating” tumor-associated macrophages by targeting NF-κB

(2008) Thorsten Hagemann et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE

Coordinate NF-κB and STAT1 Activation Promotes Development of Myeloid Type 1 Dendritic Cells

(2008) J. Vakkila et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Macrophage polarization in tumour progression

(2008) Antonio Sica et al.   SEMINARS IN CANCER BIOLOGY